Early Impact of the COVID-19 Pandemic on Acute Stroke Treatment Delays
Open Access
- 23 July 2020
- journal article
- editorial
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 48 (1) , 122-126
Abstract
This is an observational cohort study comparing 156 patients evaluated for acute stroke between March 30 and May 31, 2020 at a comprehensive stroke center with 138 patients evaluated during the corresponding time period in 2019. During the pandemic, the proportion of COVID-19 positive patients was low (3%), the time from symptom onset to hospital presentation was significantly longer, and a smaller proportion of patients underwent reperfusion therapy. Among patients directly evaluated at our institution, door-to-needle and door-to-recanalization metrics were significantly longer. Our findings support concerns that the current pandemic may have a negative impact on the management of acute stroke.Keywords
This publication has 5 references indexed in Scilit:
- Collateral Effect of Covid-19 on Stroke Evaluation in the United StatesNew England Journal of Medicine, 2020
- Acute Stroke Care Is at Risk in the Era of COVID-19Stroke, 2020
- COVID-19 and stroke—A global World Stroke Organization perspectiveInternational Journal of Stroke, 2020
- The Impact of the Covid-19 Pandemic on Stroke VolumeCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2020
- Canadian Stroke Best Practice Guidance During the COVID-19 PandemicCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2020